Please assess the completion status of the following clinical trial:

Trial Title: Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects must be ≥ 18 years old or legal age in host country.~* Subjects must have a diagnosis of primary or secondary late Stage 2 or 3 unilateral or bilateral lower extremity lymphoedema.~* At time of initial evaluation, individuals must be at least 3 months post-surgery, chemotherapy and/or radiation treatment for cancer if applicable.~* If subjects were treated in a clinic setting for lymphoedema (Phase 1 treatment) they must be at least 3 months post completion of their acute care.~Exclusion Criteria:~* Diagnosis of active or recurrent cancer, or less than 3 months at the time of initial evaluation from the completion of chemotherapy, radiation therapy or primary surgery for the treatment of cancer.~* Diagnosis of acute infection. The source of the infection must be treated for 2 weeks prior to admittance into the study.~* Diagnosis of acute thrombophlebitis (in last 2 months)~* Diagnosis of peripheral arterial disease (PAD): PAD is defined as an Ankle Brachial Index (ABI), of 0.7 or lower.~* Diagnosis of pulmonary embolism or deep vein thrombosis within the previous 6 months~* Diagnosis of pulmonary edema~* Diagnosis of congestive heart failure (uncontrolled)~* Diagnosis of chronic kidney disease with a Glomerular Filtration Rate (GFR) of less than 30 mls per minute.~* Patients with poorly controlled asthma (i.e. those with severe persistent symptoms throughout the day, night time awakenings several times per week, use of a beta2 agonist inhaler several times per day and those whose normal activity is extremely limited).~* Pregnancy~* Any condition where increased venous and lymphatic return is undesirable~* Inability or unwillingness to participate in all aspects of study protocol and/or inability to provide informed consent~* Currently participating in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Advanced PCD (Type: EXPERIMENTAL): The use of an advanced PCD device to reduce and maintain limb volume
- Simple PCD (Type: ACTIVE_COMPARATOR): The use of the Simple PCD is to reduce and maintain limb volume

Based on this trial design, predict the completion outcome and termination type (if applicable).